英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Rasagiline Impurity 40 |
|
1631061-76-1 |
詳細(xì)
|
Rasagiline Impurity 41 |
4'-C-疊氮基-3'-脫氧-3'-氟胞苷 |
1145869-46-0 |
詳細(xì)
|
Rasagiline Impurity 39 |
|
1631061-75-0 |
詳細(xì)
|
Rasagiline Impurity 36 |
|
1360459-39-7 |
詳細(xì)
|
Rasagiline Impurity 37 |
(R)-雷沙吉蘭雜質(zhì)甲磺酸鹽 |
1360459-46-6 |
詳細(xì)
|
Rasagiline Impurity 38 |
|
1631061-74-9 |
詳細(xì)
|
Polmacoxib Impurity 13 |
|
2007088-16-4 |
詳細(xì)
|
Carenoprazan Impurity 5 |
苯銹啶 |
67306-00-7 |
詳細(xì)
|
Emorfazone Impurity 11 |
|
107741-27-5 |
詳細(xì)
|
Emorfazone Impurity 12 |
|
94361-21-4 |
詳細(xì)
|
Esomeprazole Impurity 179 |
|
107711-02-4 |
詳細(xì)
|
Ondansetron Impurity 12 |
|
123638-70-0 |
詳細(xì)
|
Ondansetron Hydrochloride |
|
96223-47-1 |
詳細(xì)
|
Emorfazone Impurity 10 |
呋嘧醇 |
56425-91-3 |
詳細(xì)
|
Carenoprazan Impurity 6 |
6-[3-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol |
1246820-10-9 |
詳細(xì)
|
Carenoprazan Impurity 7 |
|
38394-98-8 |
詳細(xì)
|
Carenoprazan Impurity 8 |
17Β-氰基-17Α-羥基雄甾-4-烯-3-酮 |
77881-13-1 |
詳細(xì)
|
Emorfazone Impurity 5 |
|
214542-41-3 |
詳細(xì)
|
Emorfazone Impurity 6 |
烏諾前列酮 |
120373-36-6 |
詳細(xì)
|
Emorfazone Impurity 8 |
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide |
152658-36-1 |
詳細(xì)
|
Emorfazone Impurity 2 |
Naftifine (Z)-Isomer |
65473-08-7 |
詳細(xì)
|
Emorfazone Impurity 3 |
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol:hydrochloride |
1164469-60-6 |
詳細(xì)
|
Rasagiline Impurity 42 |
|
1030595-43-7 |
詳細(xì)
|
Rasagiline Impurity 43 |
|
1360459-02-4 |
詳細(xì)
|
Phenylbutazone Impurity 5 Sulfate (Phenylbutazone EP Impurity E Sulfate) |
AHLBNYSZXLDEJQ-HDVRVJOHSA-N |
1356930-46-5 |
詳細(xì)
|
Phenylbutazone Impurity 14 |
N-DEFORMYL-N-PIVALOYL ORLISTAT |
1356017-35-0 |
詳細(xì)
|
Phenylbutazone Impurity 15 |
N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT |
108051-94-1 |
詳細(xì)
|
Phenylbutazone Impurity 16 |
(R,S,S,S)-Orlistat Tetradecyl Ester |
1356019-45-8 |
詳細(xì)
|
Phenylbutazone Impurity 17 |
XMSSICJSZNPVFX-BMSJAHLVSA-N |
1329647-21-3 |
詳細(xì)
|
Phenylbutazone Impurity 18 |
N,N-DideMethylorphenadrine Hydrochloride |
17752-32-8 |
詳細(xì)
|
Phenylbutazone Impurity 19 |
(R)-Orphenadrine Citrate |
1202395-79-6 |
詳細(xì)
|
Polmacoxib Impurity 4 |
PT2977 |
1672668-24-4 |
詳細(xì)
|
Polmacoxib Impurity 5 |
|
1672668-51-7 |
詳細(xì)
|
Polmacoxib Impurity 6 |
|
2007088-15-3 |
詳細(xì)
|
Polmacoxib Impurity 11 |
|
1672668-35-7 |
詳細(xì)
|
Polmacoxib Impurity 12 |
|
1672668-50-6 |
詳細(xì)
|
Phenylbutazone Impurity 21 |
奧司他韋酸-D3 |
1242184-43-5 |
詳細(xì)
|
Phenylbutazone Impurity 22 |
5-(乙酰氨基)-4-氨基-3-(1-乙基丙氧基)-1-環(huán)己烯-1-羧酸 |
1391047-93-0 |
詳細(xì)
|
Phenylbutazone Impurity 23 |
(3S,4S,5R)-4-(乙酰氨基)-5-氨基-3-(1-乙基丙氧基)-1-環(huán)己烯-1-羧酸乙酯磷酸鹽 |
1035895-89-6 |
詳細(xì)
|
Phenylbutazone Impurity 24 |
OseltaMivir Acid PotassiuM Salt |
1363339-68-7 |
詳細(xì)
|
Phenylbutazone Impurity 25 |
奧司他韋雜質(zhì) |
1415963-60-8 |
詳細(xì)
|
Phenylbutazone Impurity 26 |
奧司他韋13CD3 |
1093851-61-6 |
詳細(xì)
|
Phenylbutazone Impurity 28 |
2-[4-[(E)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol |
238089-02-6 |
詳細(xì)
|
Phenylbutazone Impurity 31 |
氟氯西林雜質(zhì)7 |
42947-70-6 |
詳細(xì)
|
Phenylbutazone Impurity 32 |
氯唑芐星青霉素 |
23736-58-5 |
詳細(xì)
|
Osimertinib-13C,d3 |
奧斯替尼-13C,d3 |
2254100-49-5 |
詳細(xì)
|
Phenylbutazone Impurity 35 |
3,4-二氟肉桂酸 |
112897-97-9 |
詳細(xì)
|
Polmacoxib |
376608-67-2 |
376608-67-2 |
詳細(xì)
|
Polmacoxib Impurity 1 |
376608-68-3 |
376608-68-3 |
詳細(xì)
|
Polmacoxib Impurity 3 |
替格瑞洛雜質(zhì)8 |
378236-67-0 |
詳細(xì)
|
Polmacoxib Impurity 14 |
|
2055231-72-4 |
詳細(xì)
|
Vecabrutinib Impurity 22 |
脫氮黃素 |
26908-38-3 |
詳細(xì)
|
Vecabrutinib Impurity 23 |
四烯甲萘醌雜質(zhì)2 |
70662-30-5 |
詳細(xì)
|
Vecabrutinib Impurity 10 |
6-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline |
954264-62-1 |
詳細(xì)
|
Vecabrutinib Impurity 11 |
6,7-二甲氧基-3-甲基喹唑啉-2,4(1H,3H)-二酮 |
20197-88-0 |
詳細(xì)
|
Vecabrutinib Impurity 12 |
4-苯基-3,4-二氫喹唑啉-2(1H)-酮 |
107289-02-1 |
詳細(xì)
|
Vecabrutinib Impurity 13 |
|
119198-23-1 |
詳細(xì)
|
Vecabrutinib Impurity 14 |
2,4-二羥基-6,7-二乙氧基喹唑啉 |
20197-80-2 |
詳細(xì)
|
Vecabrutinib Impurity 15 |
|
199186-62-4 |
詳細(xì)
|
Vecabrutinib Impurity 16 |
|
199188-80-2 |
詳細(xì)
|
Vecabrutinib Impurity 17 |
3,4-二氫-3-甲基-2(1H)-喹唑啉酮 |
24365-65-9 |
詳細(xì)
|
Vecabrutinib Impurity 18 |
|
17730-75-5 |
詳細(xì)
|
Vecabrutinib Impurity 21 |
羥甲唑啉雜質(zhì)3 鹽酸鹽 |
205035-03-6 |
詳細(xì)
|
Vecabrutinib Impurity 9 |
3-(2-氯乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
110231-26-0 |
詳細(xì)
|
Vibegron |
維生素K2雜質(zhì)05 |
110327-29-2 |
詳細(xì)
|
Polmacoxib Impurity 15 |
|
2826252-90-6 |
詳細(xì)
|
Polmacoxib Impurity 16 |
|
2826252-91-7 |
詳細(xì)
|
Polmacoxib Impurity 17 |
|
2826252-92-8 |
詳細(xì)
|
Polmacoxib Impurity 18 |
|
2826252-93-9 |
詳細(xì)
|
Polmacoxib Impurity 19 |
|
2826252-94-0 |
詳細(xì)
|
Polmacoxib Impurity 20 |
|
1672668-30-2 |
詳細(xì)
|
Polmacoxib Impurity 21 |
|
2365402-28-2 |
詳細(xì)
|
Polmacoxib Impurity 22 |
|
1672668-39-1 |
詳細(xì)
|
Polmacoxib Impurity 23 |
|
1672668-44-8 |
詳細(xì)
|
Polmacoxib Impurity 24 |
|
2738682-45-4 |
詳細(xì)
|
Polmacoxib Impurity 25 |
|
2370102-07-9 |
詳細(xì)
|
Polmacoxib Impurity 26 |
|
2370015-98-6 |
詳細(xì)
|
Vecabrutinib |
3-(哌啶-4-基)-3,4-二氫喹唑啉-2(1H)-酮 |
79098-75-2 |
詳細(xì)
|
Vecabrutinib Impurity 1 |
|
79098-88-7 |
詳細(xì)
|
Vecabrutinib Impurity 2 |
6-羥基-3,4-二氫喹唑啉-2(1H)-酮 |
948552-89-4 |
詳細(xì)
|
Vecabrutinib Impurity 3 |
5-(三氟甲氧基)吲哚酮 |
403853-48-5 |
詳細(xì)
|
Vecabrutinib Impurity 4 |
8-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline |
953735-66-5 |
詳細(xì)
|
Vecabrutinib Impurity 5 |
N-(4-(三氟甲氧基)苯基)哌啶-4-胺 |
681482-48-4 |
詳細(xì)
|
Vecabrutinib Impurity 6 |
3-(2-羥基乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
110231-25-9 |
詳細(xì)
|
Vecabrutinib Impurity 7 |
3-乙基-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
335417-99-7 |
詳細(xì)
|
Vecabrutinib Impurity 8 |
3-(3-氯苯基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
364748-38-9 |
詳細(xì)
|
Vibegron Impurity 1 |
四烯甲萘醌雜質(zhì)3 |
55700-10-2 |
詳細(xì)
|
Vibegron Impurity 8 |
|
210095-51-5 |
詳細(xì)
|
Vibegron Impurity 7 |
|
2370016-14-9 |
詳細(xì)
|
Vibegron Impurity 4 |
阿哌沙班雜質(zhì)93 |
40345-06-0 |
詳細(xì)
|
Vibegron Impurity 3 |
1-(N-tryptophan)-1-deoxyfructose |
25020-15-9 |
詳細(xì)
|
Vibegron Impurity 2 |
MENAQUINONE 4 2,3-EPOXIDE |
72908-86-2 |
詳細(xì)
|
Vibegron Impurity 6 |
|
2370016-04-7 |
詳細(xì)
|
Vibegron Impurity 5 |
維貝隆雜質(zhì)5 |
2883232-91-3 |
詳細(xì)
|
Vibegron Impurity 11 |
3-丁氧基-4-硝基苯甲酸 |
72101-53-2 |
詳細(xì)
|
Vibegron Impurity 9 |
125602-69-9 |
125602-69-9 |
詳細(xì)
|
Carenoprazan |
|
2690342-18-6 |
詳細(xì)
|
Carenoprazan Impurity 2 |
2,2,3,3,4,4,5,5,6,6-decadeuterio-N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide |
1246815-53-1 |
詳細(xì)
|
Carenoprazan Impurity 3 |
奈瑪特韋雜質(zhì)34 |
2768834-00-8 |
詳細(xì)
|
Carenoprazan Impurity 4 |
奈瑪特韋雜質(zhì)32 |
2768833-99-2 |
詳細(xì)
|